Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
1995-05-25
2009-12-22
Martinell, James (Department: 1634)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C514S012200
Reexamination Certificate
active
07635466
ABSTRACT:
DNA sequences, recombinant DNA molecules and hosts transformed with them which produce polypeptides displaying a biological or immunological activity of human fibroblast interferon, the genes coding for these polypeptides and methods of making and using these DNA sequences, molecules, hosts, genes and polypeptides. The DNA sequences are characterized by in that they code for a polypeptide displaying a biological or immunological activity of human fibroblast interferon. In appropriate hosts these DNA sequences and recombinant DNA molecules permit the production and identification of genes and polypeptides displaying a biological or immunological activity of human fibroblast interferon and their use in antiviral and antitumor or anitcancer agents.
REFERENCES:
patent: 3699222 (1972-10-01), Isaacs et al.
patent: 4184917 (1980-01-01), Dorner et al.
patent: 4190495 (1980-02-01), Curtiss, III
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4241174 (1980-12-01), Familletti et al.
patent: 4262090 (1981-04-01), Colby et al.
patent: 4264731 (1981-04-01), Shine
patent: 4266024 (1981-05-01), Swetly et al.
patent: 4283489 (1981-08-01), Goodman et al.
patent: 4289850 (1981-09-01), Robinson
patent: 4293652 (1981-10-01), Cohen
patent: 4302533 (1981-11-01), Revel et al.
patent: 4307193 (1981-12-01), Iizuka
patent: 4314935 (1982-02-01), Uemura et al.
patent: 4315852 (1982-02-01), Leibowitz et al.
patent: 4322497 (1982-03-01), Hershberger
patent: 4874702 (1989-10-01), Fiers et al.
patent: 5326859 (1994-07-01), Sugano et al.
patent: 5401642 (1995-03-01), Fiers et al.
patent: 5401658 (1995-03-01), Fiers et al.
patent: 5460811 (1995-10-01), Goeddel et al.
patent: 5514567 (1996-05-01), Sugano et al.
patent: 882-545 (1980-09-01), None
patent: 887-397 (1981-06-01), None
patent: 1645 (1981-04-01), None
patent: 0 000 520 (1979-02-01), None
patent: 0 001 929 (1979-05-01), None
patent: 0 001 930 (1979-05-01), None
patent: 0 001 931 (1979-05-01), None
patent: 0 003 062 (1979-07-01), None
patent: 0 006 694 (1980-01-01), None
patent: 0 011 435 (1980-05-01), None
patent: 14050 (1980-08-01), None
patent: 0 018 218 (1980-10-01), None
patent: 26970 (1981-04-01), None
patent: 0 028 033 (1981-05-01), None
patent: 0 030 094 (1981-06-01), None
patent: 0 032 134 (1981-07-01), None
patent: 0 034 307 (1981-08-01), None
patent: 0 036 776 (1981-09-01), None
patent: 0 038 182 (1981-10-01), None
patent: 0 005 476 (1981-12-01), None
patent: 0 041 189 (1981-12-01), None
patent: 0 041 344 (1981-12-01), None
patent: 0 041 767 (1981-12-01), None
patent: 0 042 246 (1981-12-01), None
patent: 0 043 980 (1982-01-01), None
patent: 0 048 970 (1982-04-01), None
patent: 1521032 (1978-08-01), None
patent: 2031434 (1980-04-01), None
patent: 2031434 (1980-04-01), None
patent: 2037296 (1980-07-01), None
patent: 2037296 (1980-07-01), None
patent: 2055384 (1980-07-01), None
patent: 2039916 (1980-08-01), None
patent: 2052516 (1981-01-01), None
patent: 2079291 (1981-04-01), None
patent: 2061285 (1981-05-01), None
patent: 2063882 (1981-06-01), None
patent: 2068970 (1981-08-01), None
patent: 2069504 (1981-08-01), None
patent: 2071108 (1981-09-01), None
Borden, Annals of Internal Medicine 91: 472 (1979).
C. Brack et al, “An analysis of the human interferon-α gene family” (preprint). Date unavailable.
J. Tavernier et al, Evidence for a unique human fibroblast interferon (IFNβ1) chromosomal gene, devoid of intervening sequences, Laboratory of Molecular Biology (preprint). Date unavailable.
J. Treuner et al, “Successful treatment of nasopharyngeal carcinoma with interferon” (preprint). Date unavailable.
A.G. Stewart et al, “The effects of priming with human fibroblast interferon on the induction of the mRNA for interferon and other proteins”, Searle Research Laboratories (preprint). Date unavailable.
Malik, “Biotechnology And Where It Is Going” (preprint) (Malik III).
“The Production Of Interferon By ‘Genetic Engineering’”,Research Disclosure, No. 18309 (Jul. 1979).
Abstracts. Conference On Regulatory Functions Of Interferons, N.Y. Acad. Sci., (Oct. 23-26, 1979).
G. Allen and K.H. Fantes, “A Family Of Structural Genes For Human Lymphoblastoid (Leukocyte-Type) Interferon”,Nature, 287, pp. 408-411 (Oct. 2, 1980).
A.M. Arvin et al., “Interferon Prophylaxis For Simian Varicella Infection In Erythrocebus Patas Monkeys”,Abstracts, 11th Annual UCLA Symposia, Supp. No. 6, No. 246 (1982).
H. Bernard et al., “Construction Of Plasmid Cloning Vehicles That Promote Gene Expression From The Bacteriophage Lambda PLPromoter”,Gene, 5, 59-76 (1979).
W. Berthold et al., “Chemical Modifications Of Tyrosyl Residue(s) And Action Of Human-Fibroblast Interferon”,Eur. J. Biochem,, 87, 367-370 (1978).
P. Beverley and D. Knight, “Killing Comes Naturally”,Nature, 278, pp. 119-120 (1979).
A. Billiau et al., “Production, Purification And Properties Of Human Fibroblast Interferon”,Abstracts. Conference On Regulatory Functions Of Interferons, N.Y. Acad. Sci., nr. 29 (1979).
F. Bolivar et al., “Construction and Characterization Of New Cloning Vehicles. II. A Multipurpose Cloning System”,Gene, 2, pp. 95-113 (1977).
H. Boyer and D. Rouland-Dussoix, “A Complementation Analysis of The Restriction And Modification Of DNA InEscherichia coli”, J Mol. Biol., 41, pp. 459-472 (1969).
C. Brack et al., “An Analysis Of The Human Interferon-β Gene Family” (preprint).
P.J. Bridgen et al., “Human Lymphoblastoid Interferon”,J. Biol. Chem., 252, No. 19, pp. 6585-6587.
C.J. Burrell et al., “Expression InEscherichia coliof Hepatitis B Virus DNA Sequences Cloned In Plasmid pBR322”,Nature, 279, pp. 43-48 (1979).
R.L. Cavalieri et al., “Synthesis Of Human Interferon ByXenopus laevisOocytes: Two Structural Genes For Interferons In Human Cells”,Proc. Nat'l. Acad. Sci. USA, 74, pp. 3287-3291 (1977).
A.C.Y. Chang et al., “Phenotypic Expression InE. coliOf A DNA Sequence Coding For Mouse Dihydrofolate Reductase”,Nature, 275, pp. 617-624 (1978).
A.A. Creasey et al., “The Role Of GO-G1Arrest In The Inhibition Of Tumor Cell Growth By Interferon”,Abstracts. Conference On Regulatory Functions of Interferons. N.Y. Acad. Sci., nr. 17 (Oct. 23-26, 1979).
W. Degrave et al., “Nucleotide Sequence Of The Chromosomal Gene For Human Fibroblast (β1) Interferon And Of The Flanking Regions”,Gene, 14, pp. 137-143 (1981).
R. Derynck et al., “Isolation And Structure Of A Human Fibroblast Interferon Gene”,Nature, 285, pp. 542-547 (1980) (“Derynck I”).
R. Derynck et al., “Expression Of The Human Fibroblast Interfereon Gene InEscherichia coli”, (1980) (preprint) (“Derynck II”).
P.J. Farrell et al., “Interferon Action: Two Distinct Pathways For Inhibition Of Protein Synthesis By Double Stranded RNA”,Proc. Nat'l. Acad. Sci. USA, 75, pp. 5893-5897 (1978).
J. Fujisawa et al., “Nonglycosylated Mouse L Cell Interferon Produced By The Action Of Tunicamycin”,J. Biol. Chem., 253, No. 24, pp. 8677-8679 (1978).
W. Gilbert and L. Villa-Komaroff, “Useful Proteins From Recombinant Bacteria”,Scientific American, 242, pp. 74-94 (1980).
D.V. Goeddel et al., “Human Leukocyte Interferon Produced ByE. coliIs Biologically Active”,Nature, 287, pp. 411-416 (1980) (“Goeddel I”).
D.V. Goeddel et al., “The Structure Of Eight Distinct Cloned uman Leukocyte Interferon cDNAs”,Nature, 290, pp. 20-26 (1981) (“Goeddel II”).
D.V. Goeddel et al., “Synthesis Of Human Fibroblast Interferon byE.coli”, Nucleic Acids Research, 8, pp. 4057-4075 (1980) (“Goeddel III”).
H. Gray et al., “Extracellular Nucleases Of Pseudomonas BAL 31. I. Characterization Of Single-Strand-Specific Deoxyribonuclease And Double-Strand Deoxyribonuclease Activities”,Nucleic Acids Res., 2,
Biogen Idec MA Inc.
Haley Jr. James F.
Martinell James
Ropes & Gray LLP
Wong Connie
LandOfFree
DNA sequences, recombinant DNA molecules and processes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA sequences, recombinant DNA molecules and processes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA sequences, recombinant DNA molecules and processes for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4070390